1
|
Cheng HL, Wang JL, Wang XY, Wu XG, Xiao JF, Wang Y, Zheng Y, Jin X, Xu Y, He LJ, Li CB, Li TX, Zheng M, Zhao ZH, He ZY, Li JZ, Li YQ, Hong R. A torus source and its application for non-primary radiation evaluation. Phys Med Biol 2023; 68:245003. [PMID: 37549670 DOI: 10.1088/1361-6560/acede7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2023] [Accepted: 08/07/2023] [Indexed: 08/09/2023]
Abstract
Objective. Non-primary radiation doses to normal tissues from proton therapy may be associated with an increased risk of secondary malignancies, particularly in long-term survivors. Thus, a systematic method to evaluate if the dose level of non-primary radiation meets the IEC standard requirements is needed.Approach. Different from the traditional photon radiation therapy system, proton therapy systems are composed of several subsystems in a thick bunker. These subsystems are all possible sources of non-primary radiation threatening the patient. As a case study, 7 sources in the P-Cure synchrotron-based proton therapy system are modeled in Monte Carlo (MC) code: tandem injector, injection, synchrotron ring, extraction, beam transport line, scanning nozzle and concrete reflection/scattering. To accurately evaluate the synchrotron beam loss and non-primary dose, a new model called the torus source model is developed. Its parametric equations define the position and direction of the off-orbit particle bombardment on the torus pipe shell in the Cartesian coordinate system. Non-primary doses are finally calculated by several FLUKA simulations.Main results. The ratios of summarized non-primary doses from different sources to the planned dose of 2 Gy are all much smaller than the IEC requirements in both the 15-50 cm and 50-200 cm regions. Thus, the P-Cure synchrotron-based proton therapy system is clean and patient-friendly, and there is no need an inner shielding concrete between the accelerator and patient.Significance. Non-primary radiation dose level is a very important indicator to evaluate the quality of a PT system. This manuscript provides a feasible MC procedure for synchrotron-based proton therapy with new beam loss model. Which could help people figure out precisely whether this level complies with the IEC standard before the system put into clinical treatment. What' more, the torus source model could be widely used for bending magnets in gantries and synchrotrons to evaluate non-primary doses or other radiation doses.
Collapse
Affiliation(s)
- Han-Long Cheng
- University of Science and Technology of China, National Synchrotron Radiation Laboratory, Hefei 230029, People's Republic of China
- Sino-Israeli Healthy Alliance International Medical Technology Co., Ltd, AcceleratorLaboratory, Weifang 261000, People's Republic of China
| | - Jin-Long Wang
- Department of Nuclear Physics, China Institute of Atomic Energy, Beijing 102413, People's Republic of China
| | - Xiao-Yun Wang
- Sino-Israeli Healthy Alliance International Medical Technology Co., Ltd, AcceleratorLaboratory, Weifang 261000, People's Republic of China
| | - Xiao-Guang Wu
- Department of Nuclear Physics, China Institute of Atomic Energy, Beijing 102413, People's Republic of China
| | - Jie-Fang Xiao
- Sino-Israeli Healthy Alliance International Medical Technology Co., Ltd, AcceleratorLaboratory, Weifang 261000, People's Republic of China
| | - Yang Wang
- Sino-Israeli Healthy Alliance International Medical Technology Co., Ltd, AcceleratorLaboratory, Weifang 261000, People's Republic of China
| | - Yun Zheng
- Department of Nuclear Physics, China Institute of Atomic Energy, Beijing 102413, People's Republic of China
| | - Xiao Jin
- Department of Nuclear Safety, China Institute of Atomic Energy, Beijing 102413, People's Republic of China
| | - Ying Xu
- Department of Radiation Source, Nuclear and Radiation Safety Center, Beijing 102401, People's Republic of China
| | - Li-Juan He
- University of Science and Technology of China, National Synchrotron Radiation Laboratory, Hefei 230029, People's Republic of China
| | - Cong-Bo Li
- Department of Nuclear Physics, China Institute of Atomic Energy, Beijing 102413, People's Republic of China
| | - Tian-Xiao Li
- Department of Nuclear Physics, China Institute of Atomic Energy, Beijing 102413, People's Republic of China
| | - Min Zheng
- Department of Nuclear Physics, China Institute of Atomic Energy, Beijing 102413, People's Republic of China
| | - Zi-Hao Zhao
- Department of Nuclear Physics, China Institute of Atomic Energy, Beijing 102413, People's Republic of China
| | - Zi-Yang He
- Department of Nuclear Physics, China Institute of Atomic Energy, Beijing 102413, People's Republic of China
| | - Jin-Ze Li
- Department of Nuclear Physics, China Institute of Atomic Energy, Beijing 102413, People's Republic of China
| | - Yun-Qiu Li
- Department of Nuclear Physics, China Institute of Atomic Energy, Beijing 102413, People's Republic of China
| | - Rui Hong
- Department of Nuclear Physics, China Institute of Atomic Energy, Beijing 102413, People's Republic of China
| |
Collapse
|
2
|
Mirzaei M, Rowshanfarzad P, Gill S, Ebert MA, Dass J. Risk of cardiac implantable device malfunction in cancer patients receiving proton therapy: an overview. Front Oncol 2023; 13:1181450. [PMID: 37469405 PMCID: PMC10352826 DOI: 10.3389/fonc.2023.1181450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2023] [Accepted: 06/12/2023] [Indexed: 07/21/2023] Open
Abstract
Age is a risk factor for both cardiovascular disease and cancer, and as such radiation oncologists frequently see a number of patients with cardiac implantable electronic devices (CIEDs) receiving proton therapy (PT). CIED malfunctions induced by PT are nonnegligible and can occur in both passive scattering and pencil beam scanning modes. In the absence of an evidence-based protocol, the authors emphasise that this patient cohort should be managed differently to electron- and photon- external beam radiation therapy (EBRT) patients due to distinct properties of proton beams. Given the lack of a PT-specific guideline for managing this cohort and limited studies on this important topic; the process was initiated by evaluating all PT-related CIED malfunctions to provide a baseline for future reporting and research. In this review, different modes of PT and their interactions with a variety of CIEDs and pacing leads are discussed. Effects of PT on CIEDs were classified into a variety of hardware and software malfunctions. Apart from secondary neutrons, cumulative radiation dose, dose rate, CIED model/manufacturer, distance from CIED to proton field, and materials used in CIEDs/pacing leads were all evaluated to determine the probability of malfunctions. The importance of proton beam arrangements is highlighted in this study. Manufacturers should specify recommended dose limits for patients undergoing PT. The establishment of an international multidisciplinary team dedicated to CIED-bearing patients receiving PT may be beneficial.
Collapse
Affiliation(s)
- Milad Mirzaei
- Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia
- Department of Medical Imaging and Radiation Sciences, School of Biomedical Sciences, Monash University, Clayton, VIC, Australia
| | - Pejman Rowshanfarzad
- School of Physics, Mathematics and Computing, The University of Western Australia, Crawley, WA, Australia
| | - Suki Gill
- Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia
- School of Physics, Mathematics and Computing, The University of Western Australia, Crawley, WA, Australia
| | - Martin A. Ebert
- Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia
- School of Physics, Mathematics and Computing, The University of Western Australia, Crawley, WA, Australia
| | - Joshua Dass
- Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia
| |
Collapse
|
3
|
Zorloni G, Bosmans G, Brall T, Caresana M, De Saint-Hubert M, Domingo C, Ferrante C, Ferrulli F, Kopec R, Leidner J, Mares V, Nabha R, Olko P, Caballero-Pacheco MÁ, Ruehm W, Silari M, Stolarczyk L, Swakon J, Tisi M, Trinkl S, Van Hoey O, Vilches-Freixas G. Joint EURADOS WG9-WG11 rem-counter intercomparison in a Mevion S250i proton therapy facility with Hyperscan pulsed synchrocyclotron. Phys Med Biol 2022; 67:075005. [PMID: 35259730 DOI: 10.1088/1361-6560/ac5b9c] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Objective Proton therapy is gaining popularity because of the improved dose delivery over conventional radiation therapy. The secondary dose to healthy tissues is dominated by secondary neutrons. Commercial rem-counters are valuable instruments for the on-line assessment of neutron ambient dose equivalent (H*(10)). In general, however, a priori knowledge of the type of facility and of the radiation field is required for the proper choice of any survey meter. The novel Mevion S250i Hyperscan synchrocyclotron mounts the accelerator directly on the gantry. It provides a scanned 227 MeV proton beam, delivered in pulses with a pulse width of 10 µs at 750 Hz frequency, which is afterwards degraded in energy by a range shifter modulator system. This environment is particularly challenging for commercial rem-counters; therefore, we tested the reliability of some of the most widespread rem-counters to understand their limits in the Mevion S250i stray neutron field. Approach This work, promoted by the European Radiation Dosimetry Group (EURADOS), describes a rem-counter intercomparison at the Maastro Proton Therapy centre in the Netherlands, which houses the novel Mevion S250i Hyperscan system. Several rem-counters were employed in the intercomparison (LUPIN, LINUS, WENDI-II, LB6411, NM2B-458, NM2B-495Pb), which included simulation of a patient treatment protocol employing a water tank phantom. The outcomes of the experiment were compared with models and data from the literature. Main results We found that only the LUPIN allowed for a correct assessment of H*(10) within a 20% uncertainty. All other rem-counters underestimated the reference H*(10) by factors from 2 to more than 10, depending on the detector model and on the neutron dose per pulse. In pulsed fields, the neutron dose per pulse is a fundamental parameter, while the average neutron dose rate is a secondary quantity. An average 150-200 µSv/GyRBE neutron H*(10) at various positions around the phantom and at distances between 186 cm and 300 cm from it was measured per unit therapeutic dose delivered to the target. Significance Our results are partially in line with results obtained at similar Mevion facilities employing passive energy modulation. Comparisons with facilities employing active energy modulation confirmed that the neutron H*(10) can increase up to more than a factor of 10 when passive energy modulation is employed. The challenging environment of the Mevion stray neutron field requires the use of specific rem-counters sensitive to high-energy neutrons (up to a few hundred MeV) and specifically designed to withstand pulsed neutron fields.
Collapse
Affiliation(s)
| | - Geert Bosmans
- Maastricht University Medical Centre+ Oncology Centre, P. Debyelaan 25, Maastricht, Limburg, 6229, NETHERLANDS
| | - Thomas Brall
- Helmotz Zentrum Munchen, Ingolstädter Landstr. 1, Neuherberg, 85764, GERMANY
| | - Marco Caresana
- Energy, Politecnico di Milano, via Lambruschini 4, Milano, 20133, ITALY
| | - Marijke De Saint-Hubert
- Radiation protection Dosimetry and Calibration Expert Group, Belgian Nuclear Research Centre (SCK•CEN), Boeretang 200, Mol, 2400, BELGIUM
| | - Carles Domingo
- Departament de Fisica, Universidad Autonoma de Barcelona, Plaça Cívica, Bellaterra, 08193 , SPAIN
| | | | | | - Renata Kopec
- Institute of Nuclear Physics Polish Academy of Science, Walerego Eljasza Radzikowskiego 152, Krakow, 31-342, POLAND
| | | | - Vladimir Mares
- Helmholtz Zentrum Muenchen Deutsche Forschungszentrum fuer Gesundheit und Umwelt, D-85758 Neuherberg, Neuherberg, 85764 , GERMANY
| | - Racell Nabha
- Radiation protection Dosimetry and Calibration Expert Group, Belgian Nuclear Research Centre (SCK•CEN), Boeretang 200, Mol, 2400, BELGIUM
| | - Pawel Olko
- PAN, Polish Academy of Sciences, ul Radzikowskiego 152, PL 31-342, Krakow, Kraków, 31-342, POLAND
| | | | - Werner Ruehm
- Helmholtz Center Munich, Ingolstädter Landstr. 1, Neuherberg, 85764 , GERMANY
| | - Marco Silari
- CERN, Esplanade des Particules 1, Geneve, 1211, SWITZERLAND
| | - Liliana Stolarczyk
- Dansk Center for Partikelterapi, Aarhus University Hospital Skejby, Palle Juul-Jensens Boulevard 25, Aarhus, 8200, DENMARK
| | - Jan Swakon
- Institute of Nuclear Physics, Polish Academy of Sciences, Radzikowskiego 152, Krakow, 31-342, POLAND
| | - Marco Tisi
- Helmholtz Center Munich German Research Center for Environmental Health, Ingolstädter Landstr. 1, Neuherberg, Bayern, 85764, GERMANY
| | - Sebastian Trinkl
- Bundesamt fur Strahlenschutz Neuherberg, Ingolstädter Landstraße 1, Neuherberg, 85764, GERMANY
| | - Olivier Van Hoey
- Studiecentrum voor Kernenergie, Boeretang 200, Mol, 2400, BELGIUM
| | | |
Collapse
|
4
|
Yamaguchi M, Nagao Y, Kawachi N. A Simulation Study on Estimation of Bragg-Peak Shifts via Machine Learning Using Proton-Beam Images Obtained by Measurement of Secondary Electron Bremsstrahlung. IEEE TRANSACTIONS ON RADIATION AND PLASMA MEDICAL SCIENCES 2020. [DOI: 10.1109/trpms.2019.2928016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
5
|
Carnicer A, Candela-Juan C, Nirrengarten M, Blideanu V, Mazal A, Hérault J, Delacroix S. Activation of Collimators Irradiated With Clinical Proton Beams and Development of a Semiempirical Model for Activity Calculation. HEALTH PHYSICS 2019; 117:509-525. [PMID: 31211755 DOI: 10.1097/hp.0000000000001082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Patient-specific collimators used in proton therapy are activated after use. The aim of this work is to assess the residual activity in brass collimators considering clinical beams, so far studied only for monoenergetic beams, and to develop a model to calculate the activity. Eight brass collimators irradiated with different clinical and monoenergetic beams were included in the study. The collimators were analyzed with gamma spectrometry in the framework of three independent studies carried out at the two French proton therapy sites. Using FLUKA (a fully integrated particle physics Monte Carlo simulation package), simulations were performed to determine radionuclides and activities for all the collimators. The semiempirical model was built using data calculated with FLUKA for a range of clinical beams (different maximum proton energies, modulations, and doses). It was found that there was global coherence in experimental results from different studies. The relevant radionuclides at 1 mo postirradiation were Co, Co, and Zn, and additionally, Mn, Co, and Co for high-energy beams. For nondegraded monoenergetic beams, differences between FLUKA and spectrometry were within those reported in reference benchmark studies (±30%). Due to the use of perfect monochromatic sources in the FLUKA model, FLUKA results systematically underestimated experimental activities for clinical beams, especially for Zn, depending on the beam energy spread (modulation, degradation, beam line characteristics). To account for the energy spread, correction factors were derived for the semiempirical model. The model is applicable to the most relevant radionuclides and total amounts. Secondary neutrons have a negligible contribution to the activity during treatment with respect to proton activation.
Collapse
Affiliation(s)
| | | | | | - Valentin Blideanu
- Commissariat à l'énergie atomique (CEA-Saclay), Gif-sur-Yvette, France
| | - Alejandro Mazal
- Centre de Protonthérapie d'Orsay Institut Curie (ICPO), Orsay, France
| | | | - Sabine Delacroix
- Centre de Protonthérapie d'Orsay Institut Curie (ICPO), Orsay, France
| |
Collapse
|
6
|
Mathis T, Rosier L, Meniai F, Baillif S, Maschi C, Herault J, Caujolle JP, Kodjikian L, Salleron J, Thariat J. The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts. Am J Ophthalmol 2019; 201:63-71. [PMID: 30721686 DOI: 10.1016/j.ajo.2019.01.025] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2018] [Revised: 01/22/2019] [Accepted: 01/24/2019] [Indexed: 11/15/2022]
Abstract
PURPOSE To evaluate the use of the Lens Opacities Classification System III grading (LOCS III) for the characterization of radiation-induced cataract, and to correlate the proton beam projection onto the lens with cataract location and grade as defined by the LOCS III. DESIGN Prospective, interventional case series. METHODS Fifty-two consecutive patients with cataract following proton therapy were included. All cataracts were graded using LOCS III. Relationships between proton beam and cataract subtypes, as well as between dose, proportion of lens irradiated, and extent of cataracts, were assessed. RESULTS Tumor diameter, volume, stage, and equatorial tumor location were associated with extent of posterior subcapsular cataracts (PSC) that were diagnosed at a median (interquartile range) 36 months (22;83) after treatment. In multivariate analysis, the tumor volume (P < .01) and an equatorial tumor location (P = .01) were risk factors for extensive PSC. Lens irradiation was avoided in 10 patients. In the remaining 42 patients (81%), the extent of PSC significantly correlated with the dose to the lens receiving 10, 26, and 47 Gy (P = .03, P = .03, and P = .04, respectively), the dose to the lens periphery receiving 10 and 26 Gy (P = .02 and P = .02, respectively), and the dose to the ciliary body receiving 10 and 26 Gy (P = .03 and P = .02, respectively). Nuclear color significantly correlated with the dose to the ciliary body receiving 10 Gy (P = .03) and 26 Gy (P = .02). After adjustment of the results on tumor volume and tumor location, the volume of lens receiving 10 Gy (P = .04) and 26 Gy (P = .03) remained significantly associated with the extent of PSC. CONCLUSIONS Proton dose correlated with the occurrence of PSC and nuclear color cataracts as defined by LOCS III grading. Better characterization of cataracts with the LOCS III after irradiation may help to further fill gaps in the current understanding of the mechanisms of radiation-induced cataracts.
Collapse
Affiliation(s)
- Thibaud Mathis
- Department of Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France; UMR-CNRS 5510 Matéis, Villeurbane, France
| | - Laurence Rosier
- Eye Clinic, Centre d'Exploration et de Traitement de la Retine et de la Macula, Bordeaux, France
| | - Fatima Meniai
- Department of Radiation Oncology, Centre Oscar Lambret, Lille, France
| | - Stéphanie Baillif
- Department of Ophthalmology, University Hospital Pasteur 2, Nice, France
| | - Celia Maschi
- Department of Ophthalmology, University Hospital Pasteur 2, Nice, France
| | - Joël Herault
- Department of Radiation Oncology-Proton Therapy, Nice, France
| | | | - Laurent Kodjikian
- Department of Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France; UMR-CNRS 5510 Matéis, Villeurbane, France
| | - Julia Salleron
- Department of Biostatistics, Institut de Cancérologie de Lorraine, Vandoeuvre les Nancy, France
| | - Juliette Thariat
- Department of Radiation Oncology. Centre Francois Baclesse / ARCHADE - Normandie Université, Caen, France.
| |
Collapse
|
7
|
Carnicer A, Angellier G, Hofverberg P, Bergerot JM, Gerard A, Peucelle C, Vidal M, Hérault J. Study of the responses and calibration procedures of neutron and gamma area and environmental detectors for use in proton therapy. JOURNAL OF RADIOLOGICAL PROTECTION : OFFICIAL JOURNAL OF THE SOCIETY FOR RADIOLOGICAL PROTECTION 2019; 39:250-278. [PMID: 30721148 DOI: 10.1088/1361-6498/aaf437] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Ambient dose equivalent measurements with radiation protection instruments are associated to large uncertainties, mostly due to the energy dependence of the instrument response and to the dissimilarity between the spectra of the standard calibration source and the workplace field. The purpose of this work is to evaluate its impact on the performance of area and environmental detectors in the proton therapy environment, and to provide practical solutions whenever needed and possible. The study was carried out at the Centre Antoine Lacassagne (CAL) proton therapy site, and included a number of commercially available area detectors and a home-made environmental thermoluminescent dosimeter based on a polyethylene moderator loaded with TLD600H/TLD700H pairs. Monte Carlo simulations were performed with MCNP to calculate, first, missing or partially lacking instrument responses, covering the range of energies involved in proton therapy. Second, neutron and gamma spectra were computed at selected positions in and outside the CAL proton therapy bunkers. Appropriate correction factors were then derived for each detector, workplace location and calibration radionuclide source, which amounts to up to 1.9 and 1.5 for neutron and photon area detectors, respectively, and suggest that common ambient dose equivalent instruments might not meet IEC requirements. The TLD environmental system was calibrated in situ and appropriate correction factors were applied to account for the cosmic spectra. Measurements performed with this system from 2014 to 2017 around the installation were consistent with reference natural background dose data and with pre-operational levels registered at the site before the construction of the building in 1988, showing thus no contribution from the site clinical activities. An in situ verification procedure for the radiation protection instruments was also implemented in 2016 at the low energy treatment room using the QA beam reference conditions. The method presents main methodological, practical and economic advantages over external verifications.
Collapse
Affiliation(s)
- Adela Carnicer
- Centre Antoine Lacassagne (CAL), 227 avenue de la Lanterne, 06200 Nice, France. Fédération Claude Lalanne-Université Côte d'Azur, France
| | | | | | | | | | | | | | | |
Collapse
|
8
|
Mathis T, Hofverberg P, Caujolle JP, Hérault J, Leal C, Maschi C, Delaunay B, Baillif S, Kodjikian L, Thariat J. Occurrence of Phosphenes in Patients Undergoing Proton Beam Therapy for Ocular Tumor. Am J Ophthalmol 2018; 192:31-38. [PMID: 29753854 DOI: 10.1016/j.ajo.2018.05.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2018] [Revised: 04/06/2018] [Accepted: 05/02/2018] [Indexed: 11/19/2022]
Abstract
PURPOSE Phosphenes are frequently reported by patients irradiated in the head and neck area. The aim of the present study was to characterize and investigate potential mechanisms of proton beam therapy (PBT)-induced phosphenes in a large population of patients undergoing PBT for ocular tumors. DESIGN Prospective cohort study. METHODS Consecutive patients who underwent PBT in a single center were included. Immediately after the first session, all patients completed a questionnaire collecting information about the presence of phosphenes as well as their color, shape, and duration. Patient, tumor and treatment characteristics (dose volume histograms) were also collected. RESULTS Among the 474 patients included, 62.8% reported phosphenes during the first session of PBT. Reported colors were mainly blue-violet (70.5%) and white (14.1%). The prevalence of phosphenes was higher in younger patients (P = .003); other patient or ocular characteristics were not associated with the occurrence of phosphenes. Irradiation of the macula (P < .001) and/or optic disc (P < .001) were significantly associated with the presence of phosphenes, whereas blue-violet color was only associated with young age and irradiation of macular area (P = .04). Pupillary constriction was reported for 57.1% of patients with phosphenes vs 18.5% of patients without (P < .001). Blue-violet phosphenes (P < .001) and irradiation of macula (P = .001) were statistically associated with pupillary constriction. CONCLUSIONS The present study reported a high rate of phosphenes in patients irradiated by PBT for ocular tumor. Their blue-violet color and their association with a pupillary constriction probably indicates the stimulation of S-cones and retinal ganglion cells that reflects the activation of the afferent visual pathway.
Collapse
Affiliation(s)
- Thibaud Mathis
- Department of Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France; UMR-CNRS 5510 Matéis, Villeurbane, France.
| | - Petter Hofverberg
- Department of Radiation Therapy, Proton Therapy Center, Centre Antoine Lacassagne, Nice, France
| | | | - Joël Hérault
- Department of Radiation Therapy, Proton Therapy Center, Centre Antoine Lacassagne, Nice, France
| | - Cécilia Leal
- Department of Ophthalmology, Pasteur II Hospital, Nice, France
| | - Celia Maschi
- Department of Ophthalmology, Pasteur II Hospital, Nice, France
| | - Benoit Delaunay
- Department of Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France
| | | | - Laurent Kodjikian
- Department of Ophthalmology, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France; UMR-CNRS 5510 Matéis, Villeurbane, France
| | - Juliette Thariat
- Department of Radiation Therapy, Centre François Baclesse - ARCHADE, Unicaen - Normandie University, Caen, France
| |
Collapse
|
9
|
Yamaguchi M, Nagao Y, Ando K, Yamamoto S, Sakai M, Parajuli RK, Arakawa K, Kawachi N. Imaging of monochromatic beams by measuring secondary electron bremsstrahlung for carbon-ion therapy using a pinhole x-ray camera. Phys Med Biol 2018; 63:045016. [PMID: 29235991 DOI: 10.1088/1361-6560/aaa17c] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
A feasibility study on the imaging of monochromatic carbon-ion beams for carbon-ion therapy was performed. The evaluation was based on Monte Carlo simulations and beam-irradiation experiments, using a pinhole x-ray camera, which measured secondary electron bremsstrahlung (SEB). The simulation results indicated that the trajectories of the carbon-ion beams with injection energies of 278, 249 and 218 MeV/u in a water phantom, were clearly imaged by measuring the SEB with energies from 30 to 60 keV, using a pinhole camera. The Bragg-peak positions for these three injection energies were located at the positions where the ratios of the counts of SEB acquisitions to the maximum counts were approximately 0.23, 0.26 and 0.29, respectively. Moreover, we experimentally demonstrated that it was possible to identify the Bragg-peak positons, at the positions where the ratios coincided with the simulation results. However, the estimated Bragg-peak positions for the injection energies of 278 and 249 MeV/u were slightly deeper than the expected positions. In conclusion, for both the simulations and experiments, we found that the 25 mm shifts in the Bragg-peak positions can be observed by this method.
Collapse
Affiliation(s)
- Mitsutaka Yamaguchi
- Takasaki Advanced Radiation Research Institute, National Institutes for Quantum and Radiological Science and Technology, 1233 Watanuki-machi, Takasaki, Gunma, Japan. Author to whom any correspondence should be addressed
| | | | | | | | | | | | | | | |
Collapse
|
10
|
Carnicer A, Letellier V, Rucka G, Angellier G, Sauerwein W, Hérault J. An indirect in vivo dosimetry system for ocular proton therapy. RADIATION PROTECTION DOSIMETRY 2014; 161:373-376. [PMID: 24222711 DOI: 10.1093/rpd/nct284] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Secondary radiation, particularly neutron radiation, is a cause of concern in proton therapy. However, one can take advantage of its presence by using it to retrieve useful information on the primary proton beam. At the Centre Antoine Lacassagne the secondary radiation in the treatment room has been studied in function of the beam modulation. A strong correlation was found between the secondary ambient dose equivalent per proton dose H*(10)/D and proton dose rate D/MU. A large volume ionisation chamber fixed on the wall at 2.5 m from the nozzle was used with an in-house computer interface to retrieve the value of D/MU derived from the measurement of photon H*(10) integrated over treatment time, using the correlation curve. This system enables the verification of D and D/MU to be made independently of the monitoring of the primary beam and represents a first step towards an alternative in vivo dosimetry in proton therapy.
Collapse
Affiliation(s)
- A Carnicer
- Cyclotron Biomédical, Centre Antoine Lacassagne, 227 Avenue de la Lanterne, 06200 Nice, France
| | - V Letellier
- Centre de protonthérapie, Institut Curie, Campus Universitaire d'Orsay, bâtiment 101, 91898 Orsay Cedex, France
| | - G Rucka
- Centre de radiothérapie St Louis, Hôpital de la Croix Rouge, rue André Blondel, 83100 Toulon France
| | - G Angellier
- Cyclotron Biomédical, Centre Antoine Lacassagne, 227 Avenue de la Lanterne, 06200 Nice, France
| | - W Sauerwein
- Universitätsklinikum Essen, Strahlenklink, 45122 Essen, Germany
| | - J Hérault
- Cyclotron Biomédical, Centre Antoine Lacassagne, 227 Avenue de la Lanterne, 06200 Nice, France
| |
Collapse
|
11
|
Carnicer A, Angellier G, Gérard A, Garnier N, Dubois C, Amblard R, Hérault J. Development and validation of radiochromic film dosimetry and Monte Carlo simulation tools for acquisition of absolute, high-spatial resolution longitudinal dose distributions in ocular proton therapy. RADIAT MEAS 2013. [DOI: 10.1016/j.radmeas.2013.06.011] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|